A Single-Arm, Prospective Study of Papaverine for the Treatment of Refractory Peripheral Neuropathy Induced by Taxane-Based Chemotherapy

NCT07572461 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy-Induced Peripheral Neuropathy
Refractory Chemotherapy-Induced Peripheral Neuropathy
Paclitaxel-Induced Peripheral Neuropathy

Interventions

DRUG: Papaverine hydrochloride injection

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University